EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Antimicrobial Susceptibility with Treatment Response in Mycobacterium avium complex Pulmonary Disease

Xuejiao Luo, Yuhang Chen iD, Lina Davies Forsman, Yifan He, Guoling Yang, Wei Wei, Hai Lou, Li Wang iD, Lan Yao, Yidian Liu, Judith Bruchfeld, Jan-Willem Alffenaar iD und 3 weitere

Pathogens · 2025

DOI: 10.3390/pathogens14121218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Xuejiao Luo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji Universi…. Hauptthemen laut MEDLINE: Mycobacterium avium Complex, Mycobacterium avium-intracellulare Infection, Anti-Bacterial Agents, Lung Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the clinical implications of minimum inhibitory concentration (MIC) may facilitate optimal drug selection in Mycobacterium avium complex pulmonary disease (MAC-PD) treatment. This study aimed to investigate the association of individual MICs with treatment response of MAC-PD. A retrospective cohort study was conducted in China, including eligible patients diagnosed with MAC-PD between 2018 and 2021. Treatment success rates were calculated across different MIC levels in a subgroup of patients receiving relatively uniform regimens. Associations between MICs and treatment outcomes were investigated by logistic regression analysis. In total, 209 patients with confirmed MAC-PD and initiated treatment were included. The median age was 60.0 years. Among 155 patients who completed treatment, 67.1% achieved treatment success. The treatment success rate was low in patients with clarithromycin MIC ≥ 64 mg/L (25.0%, 1/4) or ethambutol MIC > 16 mg/L (42.9%, 3/7), while remaining relatively stable (75–100%) at other MIC levels. Univariate analyses showed that clarithromycin and ethambutol MICs above these thresholds were associated with increased risk of treatment failure. Our findings suggest an association between clarithromycin MICs and treatment outcomes in patients with MAC-PD receiving standard guideline-recommended regimens. Meanwhile, elevated ethambutol MICs exhibited potential clinical relevance, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAnti-Bacterial AgentsLung DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesMicrobial Sensitivity TestsClarithromycinAgedEthambutolTreatment OutcomeChinaAdult

Stichwörter der Autor:innen

Mycobacterium avium complexminimum inhibitory concentrationpulmonary diseasetreatment outcome

Substanzen

ClarithromycinAnti-Bacterial AgentsEthambutol

Autor:innen und Institutionen

  • Clinic and Research Centre of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
  • Division of Infectious Diseases, Department of Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, 17176 Stockholm, Sweden.
  • Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW 2006, Australia.
  • Westmead Hospital, Syndney, NSW 2145, Australia.

ORCID-Profile: Yuhang Chen, Li Wang, Jan-Willem Alffenaar, Biao Xu

Förderung

  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • Shanghai Municipal Health Commission

Zitieren

APA

Luo, X., Chen, Y., Forsman, L. D., He, Y., Yang, G., Wei, W., Lou, H., Wang, L., Yao, L., Liu, Y., Bruchfeld, J., Alffenaar, J. W., Xu, B., Zheng, X., & Sha, W. (2025). Association of Antimicrobial Susceptibility with Treatment Response in Mycobacterium avium complex Pulmonary Disease. Pathogens. https://doi.org/10.3390/pathogens14121218

Vancouver

Luo X, Chen Y, Forsman LD, He Y, Yang G, Wei W, et al. Association of Antimicrobial Susceptibility with Treatment Response in Mycobacterium avium complex Pulmonary Disease. Pathogens. 2025. doi:10.3390/pathogens14121218

BibTeX
@article{Luo2025,
  author = {Luo, Xuejiao and Chen, Yuhang and Forsman, Lina Davies and He, Yifan and Yang, Guoling and Wei, Wei and Lou, Hai and Wang, Li and Yao, Lan and Liu, Yidian and Bruchfeld, Judith and Alffenaar, Jan-Willem and Xu, Biao and Zheng, Xubin and Sha, Wei},
  title = {Association of Antimicrobial Susceptibility with Treatment Response in Mycobacterium avium complex Pulmonary Disease},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14121218}
}
Kostenlos starten →